Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
12,602,265
-
Total 13F shares
-
7,399,363
-
Share change
-
+508,985
-
Total reported value
-
$719,876,156
-
Price per share
-
$97.28
-
Number of holders
-
214
-
Value change
-
+$50,633,803
-
Number of buys
-
109
-
Number of sells
-
86
Institutional Holders of IRADIMED CORP - Common (IRMD) as of Q4 2025
As of 31 Dec 2025,
IRADIMED CORP - Common (IRMD) was held by
214 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,399,363 shares.
The largest 10 holders included
BlackRock, Inc., VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, Nine Ten Capital Management LLC, Copeland Capital Management, LLC, KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, T. Rowe Price Investment Management, Inc., DIMENSIONAL FUND ADVISORS LP, and GOLDMAN SACHS GROUP INC.
This page lists
214
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.